Video! Ziosoft has been trying to unlock the U.S. market for advanced visualization for several years. It may have found the key with a technology unveiled this week at RSNA2010.
Ziosoft has been trying to unlock the U.S. market for advanced visualization for several years. It may have found the key with a technology unveiled this week at RSNA2010.
Producing images that border on photorealism, ZioSoft’s new PhyZiodynamic algorithms take postprocessing to a new level, one the Japanese company describes as “functional imaging analytics.” Image data are not only visually striking but measurable and highly reproducible, according to Rob Royea, president and COO for Ziosoft, adding objectivity to what has typically been a subjective medium.
High-resolution 2D data are processed into high-fidelity 3D renderings, which are then animated to demonstrate real-time action. Four-dimensional loops portray dynamic volumetric imaging that allows functional analyses.
The new algorithms are powered by a supercomputing architecture that supports the rendering of 3D and 4D images. The company has harnessed these algorithms to drive functional analysis available on its MR Cardiac Analysis suite on its Ziostation system. Other analyses supported by the algorithms are designed to depict coronary vessels, time intensity, time-delayed signal intensity, and strain analysis of the heart. These are only sold outside the U.S.
PhyZiodynamics is a generational leap ahead in advanced visualization, according to Royea. The underlying basis of the technology is its ability to process images quickly and without data loss, thereby ensuring true fidelity renderings from any DICOM imaging modality.
Because the new PhyZiodynamic offerings are networked, as are all Ziosoft-based technologies, processed images are accessible anywhere throughout the enterprise with multiple concurrent users per off-the-shelf server.
In addition to its new PhyZiodynamic algorithms, the company will feature at its booth a new specialized liver analysis application for surgical and treatment planning. This application allows automatic segmentation of the liver. A guided workflow “wizard" breaks vascular structure, hepatic lobes, and lesions into segments.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.